UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study

Acta dermato-venereologica, 2022-01, Vol.102, p.adv00626-adv00626

2022

Volltextzugriff (PDF)

Health Literacy and Associated Factors in Subjects with Hand Eczema: A Dutch Population-based Study

Acta dermato-venereologica, 2024-05, Vol.104, p.adv40079-adv40079

2024

Volltextzugriff (PDF)

Health literacy in adult patients with atopic dermatitis: A cross-sectional study

The journal of allergy and clinical immunology. Global, 2024-05, Vol.3 (2), p.100218-100218, Article 100218

2024

Volltextzugriff (PDF)

Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis

Acta dermato-venereologica, 2023-08, Vol.103, p.adv9378-adv9378

2023

Volltextzugriff (PDF)

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

Acta dermato-venereologica, 2024-02, Vol.104, p.adv19454-adv19454

2024

Volltextzugriff (PDF)

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry

Acta dermato-venereologica, 2022-11, Vol.102, p.adv00820

2022

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population

JAAD international, 2022-03, Vol.6, p.86-93

2022

Volltextzugriff (PDF)

33552 Prevalence and severity of atopic dermatitis and hand eczema, and associated lifestyle factors in the Dutch general population

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB95-AB95

2022

Volltextzugriff (PDF)

42622 Association between severity of atopic dermatitis, mental disorders and loneliness in adults in the Dutch general population

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB124-AB124

2023

Volltextzugriff (PDF)

Hand eczema and lifestyle factors in the D utch general population: Evidence for smoking, chronic stress, and obesity

Contact dermatitis, 2022-02, Vol.86 (2), p.80-88

2022

Volltextzugriff (PDF)

Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study

Acta dermato-venereologica, 2022-01, Vol.102

2022

Volltextzugriff (PDF)

Hand eczema and lifestyle factors in the Dutch general population: Evidence for smoking, chronic stress, and obesity

Contact dermatitis, 2022-02, Vol.86 (2), p.80-88

2022

Volltextzugriff (PDF)

Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population

Clinical and experimental dermatology, 2022-08, Vol.47 (8), p.1523-1535

2022

Volltextzugriff (PDF)

Limited Health Literacy and Its Associated Health Outcomes Among Adults With at Least 2 Atopic Diseases

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-05, Vol.11 (5), p.1429-1438.e6

2023

Volltextzugriff (PDF)

Baricitinib treatment of severe chronic hand eczema: Two case reports

Contact dermatitis, 2022-05, Vol.86 (5), p.419-421

2022

Volltextzugriff (PDF)

Exposure and work‐related factors in subjects with hand eczema: Data from a cross‐sectional questionnaire within the Lifelines Cohort Study

Contact dermatitis, 2022-06, Vol.86 (6), p.493-506

2022

Volltextzugriff (PDF)

Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry

Contact dermatitis, 2023-05, Vol.88 (5), p.351-362

2023

Volltextzugriff (PDF)

Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab

Contact dermatitis, 2021-02, Vol.84 (2), p.124-127

2021

Volltextzugriff (PDF)

A genome‐wide association study of hand eczema identifies locus 20q13.33 and reveals genetic overlap with atopic dermatitis

Contact dermatitis, 2024-09, Vol.91 (3), p.190-202

2024

Volltextzugriff (PDF)

Hand eczema‐related presenteeism and sickness absence: A cross‐sectional population‐based study

Contact dermatitis, 2024-04, Vol.90 (4), p.372-377

2024

Volltextzugriff (PDF)

Validity, reliability, responsiveness, and interpretability of the Recap of atopic eczema (RECAP) questionnaire

British journal of dermatology (1951), 2023-10, Vol.189 (5), p.578-587

2023

Volltextzugriff (PDF)

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Allergy (Copenhagen), 2022-11, Vol.77 (11), p.3398-3407

2022

Volltextzugriff (PDF)

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry

JAMA dermatology (Chicago, Ill.), 2022-09, Vol.158 (9), p.1048

2022

Volltextzugriff (PDF)

Lifestyle factors and hand eczema: A systematic review and meta‐analysis of observational studies

Contact dermatitis, 2022-09, Vol.87 (3), p.211-232

2022

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study

Health Literacy and Associated Factors in Subjects with Hand Eczema: A Dutch Population-based Study

Health literacy in adult patients with atopic dermatitis: A cross-sectional study

Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry

Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population

33552 Prevalence and severity of atopic dermatitis and hand eczema, and associated lifestyle factors in the Dutch general population

42622 Association between severity of atopic dermatitis, mental disorders and loneliness in adults in the Dutch general population

Hand eczema and lifestyle factors in the D utch general population: Evidence for smoking, chronic stress, and obesity

Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study

Hand eczema and lifestyle factors in the Dutch general population: Evidence for smoking, chronic stress, and obesity

Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population

Limited Health Literacy and Its Associated Health Outcomes Among Adults With at Least 2 Atopic Diseases

Baricitinib treatment of severe chronic hand eczema: Two case reports

Exposure and work‐related factors in subjects with hand eczema: Data from a cross‐sectional questionnaire within the Lifelines Cohort Study

Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry

Three cases of non‐atopic hyperkeratotic hand eczema treated with dupilumab

A genome‐wide association study of hand eczema identifies locus 20q13.33 and reveals genetic overlap with atopic dermatitis

Hand eczema‐related presenteeism and sickness absence: A cross‐sectional population‐based study

Validity, reliability, responsiveness, and interpretability of the Recap of atopic eczema (RECAP) questionnaire

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry

Lifestyle factors and hand eczema: A systematic review and meta‐analysis of observational studies

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry

Suchergebnisse filtern